Feb 15, 2017. 1  Mark Bertolini, CEO of health insurance titan Aetna (aet), isn't holding back when it comes to Obamacare. 2  Bertolini said that he believes Obamacare is in a death spiral at a Wall Street Journal event, according to Politico.
Synagis is indicated for the prevention of serious lower respiratory tract disease requiring hospitalisation caused by respiratory syncytial virus (RSV) in children at high risk for RSV disease: â¢ Children born at 35 weeks of gestation or less and less than 6 months of age at the onset of the RSV season.
(Redirected from Synagis) Palivizumab (brand name Synagis which is manufactured by MedImmune) is a monoclonal antibody produced by recombinant DNA technology. It is used in the prevention of respiratory syncytial virus (RSV) infections. It is recommended for infants that are high-risk because of prematurity or other medical problems such as congenital heart disease.